Intestinal microbiota in allergic and nonallergic 1-year-old very low birth weight infants after neonatal glutamine

A Van Zwol1, A Van Den Berg, J Knol

  • 1Department of Pediatrics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.

Insights

Glutamine-enriched nutrition did not alter gut bacteria linked to allergies in very low birth weight infants. However, allergic infants showed lower bifidobacteria colonization, suggesting a potential link to atopic dermatitis development.

Area of Science:

  • Neonatal nutrition and immunology
  • Microbiome research
  • Allergy development in infants

Background:

  • Previous studies indicated glutamine-enriched enteral nutrition reduces atopic dermatitis in very low birth weight (VLBW) infants.
  • The underlying mechanisms, particularly shifts in intestinal microbiota associated with allergies, remain unclear.

Purpose of the Study:

  • To investigate if glutamine supplementation influences specific intestinal bacterial species (Bifidobacteria, Clostridium histolyticum/lituseburense group, Escherichia coli) at one year of age.
  • To determine the relationship between these bacterial changes and the incidence of atopic dermatitis in VLBW infants.

Main Methods:

  • A follow-up study involving 89 VLBW infants, with 72 participating at one year.
  • Faecal samples analyzed for Bifidobacteria, Clostridium histolyticum/lituseburense (Chis/lit) group, and E. coli using fluorescent in situ hybridization.
  • Allergic and infectious disease data collected via questionnaires.

Main Results:

  • No significant differences in the prevalence of studied bacterial species were found between glutamine-supplemented and control groups.
  • Allergic infants exhibited lower colonization rates of Bifidobacteria compared to non-allergic infants (p=0.04).
  • Over the first year, Bifidobacteria prevalence increased (p<0.001), Chis/lit group remained stable (p=0.84), and E. coli decreased (p<0.001).

Conclusions:

  • The protective effect of glutamine-enriched nutrition against atopic dermatitis in VLBW infants is not mediated by alterations in Bifidobacteria, Chis/lit group, or E. coli.
  • Lower Bifidobacteria colonization is associated with allergic VLBW infants, suggesting a potential role in allergy development.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...